Skip to main content

Amylyx Pharmaceuticals, Inc.

AMLX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001658551

In the last 90 days, Amylyx Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 6 sales; 206 institutions reported holding it in 13F filings for Q2 2026, worth $2.07B in total; no superinvestor holds it.

13F holders, Q3 2024

Institutional positions in Amylyx Pharmaceuticals, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
110
−8 vs. Q2 2024
Shares held
43.5M
+2.49M (+6.1%) vs. Q2 2024
Total value
$140.8M
+$62.9M (+80.8%) vs. Q2 2024
New holders
23
32 more added
Sold out
31
35 more reduced

1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting AMLX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2024: 110 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 72 institutionsQ2 2022: 78 institutionsQ3 2022: 95 institutionsQ4 2022: 133 institutionsQ1 2023: 147 institutionsQ2 2023: 154 institutionsQ3 2023: 170 institutionsQ4 2023: 178 institutionsQ1 2024: 143 institutionsQ2 2024: 119 institutionsQ3 2024: 110 institutionsQ4 2024: 122 institutionsQ1 2025: 136 institutionsQ2 2025: 131 institutionsQ3 2025: 169 institutionsQ4 2025: 180 institutionsQ1 2026: 171 institutionsQ2 2026: 206 institutions
Value heldQ3 2024: $140.8M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $299.9MQ2 2022: $512.9MQ3 2022: $1.05BQ4 2022: $1.79BQ1 2023: $1.51BQ2 2023: $1.18BQ3 2023: $1.08BQ4 2023: $887.4MQ1 2024: $141.5MQ2 2024: $82.9MQ3 2024: $140.8MQ4 2024: $188.3MQ1 2025: $261.6MQ2 2025: $523.6MQ3 2025: $1.49BQ4 2025: $1.36BQ1 2026: $1.59BQ2 2026: $2.07B
Institutions holding AMLX and their total value by quarter
QuarterHoldersValue
Q2 2026206$2.07B
Q1 2026171$1.59B
Q4 2025180$1.36B
Q3 2025169$1.49B
Q2 2025131$523.6M
Q1 2025136$261.6M
Q4 2024122$188.3M
Q3 2024110$140.8M
Q2 2024119$82.9M
Q1 2024143$141.5M
Q4 2023178$887.4M
Q3 2023170$1.08B
Q2 2023154$1.18B
Q1 2023147$1.51B
Q4 2022133$1.79B
Q3 202295$1.05B
Q2 202278$512.9M
Q1 202272$299.9M
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q3 2024

Shares, value and share of portfolio for each institution holding Amylyx Pharmaceuticals, Inc.; share changes are against Q2 2024.

Institutions holding AMLX in Q3 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Acadian Asset Management LLC1,770,197$5.73M0.02%+558,580+46.1%Added
Citadel Advisors LLC1,899,560$6.15M0.01%+554,742+41.3%Added
Standard Life Aberdeen plc1,972,242$6.39M0.01%+1,853,995+1,567.9%Added
Almitas Capital LLC1,988,563$6.44M2.28%+84,712+4.4%Added
683 Capital Management, LLC2,000,000$6.48M0.66%+498,129+33.2%Added
Alyeska Investment Group, L.P.2,023,420$6.56M0.03%+200,000+11.0%Added
Perceptive Advisors LLC2,125,649$6.89M0.15%+2,125,649New
BlackRock, Inc.2,548,206$8.26M0.00%+2,548,206New
Vanguard Group Inc3,089,645$10.0M0.00%−1,134,323−26.9%Reduced
TCG Crossover Management, LLC4,643,812$15.0M1.27%+4,643,812New
Boxer Capital, LLC0$00.00%−1,500,000−100.0%Sold out
Woodline Partners LP0$00.00%−523,772−100.0%Sold out
Aviva PLC0$00.00%−363,032−100.0%Sold out
Sofinnova Investments, Inc.0$00.00%−299,691−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−250,000−100.0%Sold out
State of Wisconsin Investment Board0$00.00%−138,500−100.0%Sold out
Y-Intercept (Hong Kong) Ltd0$00.00%−118,105−100.0%Sold out
LMR Partners LLP0$00.00%−113,300−100.0%Sold out
Alpine Global Management, LLC0$00.00%−108,862−100.0%Sold out
Maven Securities LTD0$00.00%−100,000−100.0%Sold out
Centiva Capital, LP0$00.00%−90,733−100.0%Sold out
Alps Advisors Inc0$00.00%−90,357−100.0%Sold out
Engineers Gate Manager LP0$00.00%−84,044−100.0%Sold out
Paloma Partners Management Co0$00.00%−57,954−100.0%Sold out
Sphera Funds Management Ltd.0$00.00%−36,050−100.0%Sold out
Cerity Partners LLC0$00.00%−33,365−100.0%Sold out
Allspring Global Investments Holdings, LLC0$00.00%−28,785−100.0%Sold out
Rhumbline Advisers0$00.00%−28,779−100.0%Sold out
Mirae Asset Global ETFs Holdings Ltd.0$00.00%−26,032−100.0%Sold out
Point72 (DIFC) Ltd0$00.00%−25,953−100.0%Sold out
Zuckerman Investment Group, LLC0$00.00%−20,000−100.0%Sold out
Jump Financial, LLC0$00.00%−17,685−100.0%Sold out
ProShare Advisors LLC0$00.00%−11,000−100.0%Sold out
Teza Capital Management LLC0$00.00%−10,160−100.0%Sold out
Banque Cantonale Vaudoise0$00.00%−5,900−100.0%Sold out
Macquarie Group Ltd0$00.00%−2,528−100.0%Sold out
Caption Management, LLC0$00.00%−1,200−100.0%Sold out
New York State Common Retirement Fund0$00.00%−444−100.0%Sold out
Redwood Wealth Management Group, LLC0$00.00%−200−100.0%Sold out
Kelly Financial Services LLC0$00.00%−33−100.0%Sold out
Covestor Ltd0$00.00%−43−100.0%Sold out
BlackRock Inc.––––Not filed